CellaVision AB Statistics
Total Valuation
CellaVision AB has a market cap or net worth of 398.88 million. The enterprise value is 384.17 million.
| Market Cap | 398.88M |
| Enterprise Value | 384.17M |
Important Dates
The last earnings date was Thursday, February 5, 2026.
| Earnings Date | Feb 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 23.85M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.31% |
| Owned by Institutions (%) | 59.63% |
| Float | 19.72M |
Valuation Ratios
The trailing PE ratio is 24.82 and the forward PE ratio is 20.45.
| PE Ratio | 24.82 |
| Forward PE | 20.45 |
| PS Ratio | 5.02 |
| PB Ratio | 4.41 |
| P/TBV Ratio | 5.84 |
| P/FCF Ratio | 21.55 |
| P/OCF Ratio | 19.27 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.96, with an EV/FCF ratio of 20.76.
| EV / Earnings | 23.91 |
| EV / Sales | 4.59 |
| EV / EBITDA | 14.96 |
| EV / EBIT | 17.31 |
| EV / FCF | 20.76 |
Financial Position
The company has a current ratio of 3.31, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.31 |
| Quick Ratio | 2.43 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | 0.16 |
| Interest Coverage | 31.85 |
Financial Efficiency
Return on equity (ROE) is 18.70% and return on invested capital (ROIC) is 22.15%.
| Return on Equity (ROE) | 18.70% |
| Return on Assets (ROA) | 12.03% |
| Return on Invested Capital (ROIC) | 22.15% |
| Return on Capital Employed (ROCE) | 20.93% |
| Weighted Average Cost of Capital (WACC) | 11.43% |
| Revenue Per Employee | 343,852 |
| Profits Per Employee | 69,558 |
| Employee Count | 231 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 2.03 |
Taxes
In the past 12 months, CellaVision AB has paid 4.22 million in taxes.
| Income Tax | 4.22M |
| Effective Tax Rate | 20.82% |
Stock Price Statistics
The stock price has decreased by -17.79% in the last 52 weeks. The beta is 1.30, so CellaVision AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.30 |
| 52-Week Price Change | -17.79% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 41.82 |
| Average Volume (20 Days) | 438 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CellaVision AB had revenue of 79.43 million and earned 16.07 million in profits. Earnings per share was 0.67.
| Revenue | 79.43M |
| Gross Profit | 54.89M |
| Operating Income | 21.05M |
| Pretax Income | 20.29M |
| Net Income | 16.07M |
| EBITDA | 23.08M |
| EBIT | 21.05M |
| Earnings Per Share (EPS) | 0.67 |
Balance Sheet
The company has 16.84 million in cash and 2.89 million in debt, with a net cash position of 13.95 million.
| Cash & Cash Equivalents | 16.84M |
| Total Debt | 2.89M |
| Net Cash | 13.95M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 90.37M |
| Book Value Per Share | 3.79 |
| Working Capital | 31.52M |
Cash Flow
In the last 12 months, operating cash flow was 20.70 million and capital expenditures -2.20 million, giving a free cash flow of 18.51 million.
| Operating Cash Flow | 20.70M |
| Capital Expenditures | -2.20M |
| Free Cash Flow | 18.51M |
| FCF Per Share | n/a |
Margins
Gross margin is 69.11%, with operating and profit margins of 26.50% and 20.23%.
| Gross Margin | 69.11% |
| Operating Margin | 26.50% |
| Pretax Margin | 25.55% |
| Profit Margin | 20.23% |
| EBITDA Margin | 29.06% |
| EBIT Margin | 26.50% |
| FCF Margin | 23.30% |
Dividends & Yields
CellaVision AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 39.38% |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 4.03% |
| FCF Yield | 4.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |